Skip to content

Author

A. Dhali

We have 7 of 232 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Beyond histocompatibility: human leukocyte antigen as a cross-disciplinary platform for immune recognition and clinical decision-making

Human leukocyte antigen (HLA) molecules mediate peptide presentation and shape immune recognition, with clinical relevance well beyond donor-recipient matching. This review describes how HLA variation and anti-HLA immunity affect transfusion medicine, autoimmune and infectious diseases, pharmacogenomics, cancer, pregna...

Saikat Mandal, Joyisa Deb, Aswin K. Mohan et al. · 0 citations
Open access Sep 2026

Burden of Pancreatitis in the United States from 1990 to 2023: Findings from the Global Burden of Disease Study 2023

Objectives: Pancreatitis is the third leading cause of gastrointestinal disease-related hospitalization. Pancreatitis burden has continued to increase since 1990, with trends driven by changing exposures to risk factors, population growth, and population aging. We report the national- and state-level estimates of pancr...

M. M. Reddy, Anish Chopra, G. Aswath et al. · 0 citations
Open access Sep 2026

Validation and Performance of Five Upper Gastrointestinal Bleeding Prognostication Scores in a Single-Centre United Kingdom Cohort of over 1000 Patients

Objectives: Upper gastrointestinal bleeding (UGIB) is a common medical emergency associated with substantial morbidity and mortality. Several clinical risk scores are available, but their comparative performance across outcomes and patient subgroups remains uncertain. We compared five established UGIB risk scores for p...

Mohamed Jalloh, Balamrit Singh Sokhal, Maryam Javed et al. · 0 citations
Open access Sep 2026

Deaths Mentioning Both Pancreatic Cancer and Renal Failure in the United States, 1999–2024: Temporal Trends and Disparities

Background: We examined temporal trends in deaths mentioning both pancreatic cancer and renal failure in the United States. Methods: We analyzed CDC WONDER multiple-cause-of-death data for adults aged ≥25 years from 1999 to 2024. Age-adjusted mortality rates (AAMRs) were assessed using Joinpoint regression. Secondary a...

A. Dhali, Ali Shan Hafeez, J. Biswas et al. · 0 citations
Review Open access Sep 2026

Safety and Efficiency of Robotic Versus Laparoscopic Revisional Bariatric Surgery: A Systematic Review and Meta-Analysis

Findings should be interpreted as hypothesis-generating rather than definitive evidence of superiority or equivalence, but larger, prospective, multi-centre studies with standardised outcome definitions and robust adjustment for confounding are needed to clarify the comparative clinical and cost-effectiveness of roboti...

H. Bharadwaj, E. Danda, S. H. Ali et al. · 0 citations
Open access Aug 2026

Trends and Disparities in Mortality Involving Pancreatic Cancer and Pulmonary Embolism in the United States, 1999–2024: A CDC WONDER Analysis

Mortality involving pancreatic cancer and PE increased substantially in the United States, and PE was recorded in a growing proportion of pancreatic cancer deaths, and PE was recorded in a growing proportion of pancreatic cancer deaths.

A. Dhali, J. Biswas, Ali Shan Hafeez et al. · 0 citations
Review Open access Aug 2026

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023–2026 evidence and a proposed clinical integration framework

A narrative review synthesizes evidence published between 2020 and 2026 within a unified clinical framework not provided by prior reviews, and proposes an original biomarker-guided clinical algorithm, a comparative clinical readiness table, and a disease-continuum biomarker timeline as practical tools for clinicians an...

Ashish Sharma, J. Tan, Rajvardhan Sisodia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.